Publications by authors named "Wei Zhi Tan"

Background: Higher resistance rates of > 20% have been noted in Enterobacteriaceae urinary isolates towards ciprofloxacin and co-trimoxazole (C + C) in Singapore, compared with amoxicillin-clavulanate and nitrofurantoin (AC + N). This study examined if treatment failure varied between different antibiotics, given different resistant rates, for uncomplicated urinary tract infections (UTIs) managed in primary care. We also aimed to identify gaps for improvement in diagnosis, investigations, and management.

View Article and Find Full Text PDF

Background: Antibiotic prescription practices in primary care in Singapore have received little scholarly attention. In this study, we ascertained prescription prevalence and identified care gaps and predisposing factors.

Methods: A retrospective study was conducted on adults (>21 years old) at six public primary care clinics in Singapore.

View Article and Find Full Text PDF

While bacteria can be beneficial to our health, their deadly pathogenic potential has been an ever-present concern exacerbated by the emergence of drug-resistant strains. As such, there is a pressing urgency for an enhanced understanding of their gene function and regulation, which could mediate the development of novel antimicrobials. Transcriptomic analyses have been established as insightful and indispensable to the functional characterization of genes and identification of new biological pathways, but in the context of bacterial studies, they remain limited to species-specific datasets.

View Article and Find Full Text PDF
Article Synopsis
  • Thiopurines are commonly used for treating inflammatory bowel disease (IBD) but can cause significant variability in patient responses and side effects due to genetic differences.
  • A study involving 149 multiethnic Asian IBD patients identified two FTO gene variants, revealing that one variant (rs16952570) showed differing prevalence among ethnic groups and was linked to better white blood cell counts in patients after starting thiopurine therapy.
  • The research suggests that the FTO variant rs16952570 CC genotype may provide a protective effect on blood cell levels in patients undergoing thiopurine treatment, highlighting the importance of genetic testing in personalized medicine for IBD.
View Article and Find Full Text PDF